Division-Wide Expertise
The CSRU includes investigators from across the division with an aim of increasing trans-divisional survivorship research studies, but is housed in the Radiation Epidemiology Branch, building on the branch’s long-standing expertise in studying subsequent malignancy risks and late effects of cancer treatment.
CSRU activities are complemented by monthly seminars coordinated by the DCEG Cancer Survivorship Working Group, co-chaired by Drs. Shahinaz Gadalla, Lindsay Morton, Sara Schonfeld, and Jacqueline Vo.
Research Studies
Current studies led by CSRU members include a broad range of cancer survivor populations (e.g., pediatric cancer, breast cancer, hematologic malignancies), consider special populations (e.g., individuals with inherited cancer predisposition syndromes, hematopoietic stem cell transplant recipients), and assess a range of outcomes.
Survivor Populations by Cancer Type
Breast Cancer
- Confluence Project
- Kaiser Permanente Breast Cancer Survivors Cohort
- Ultrasound Study of the Effects of Tamoxifen on Breast Tissue
Pediatric Cancers
Special Populations
- HIV/AIDS Cancer Match Study
- Inherited Bone Marrow Failure Syndromes (IBMFS)
- Li-Fraumeni Syndrome Study
- Neurofibromatosis Type 1 and Cancer Susceptibility
- Pleuropulmonary Blastoma DICER1 Syndrome Study
- Retinoblastoma Survivors Follow-up Study
- Second Primary Gastrointestinal Cancers
- Transplant Cancer Match Study
Methods and Outcomes
- Psychosocial Effects of Cancer Predisposition Syndromes
- Hematopoietic Stem Cell Transplantation and Risks of Second Cancers
- Predictors of Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
- Radiation Dose Reconstruction
- Temporal Trends in Second Cancer Risks Based on SEER Data
For more information, contact Lindsay Morton, Ph.D.